The ministry's own page records that in June 2013 it temporarily withheld proactive recommendation of the HPV vaccine over adverse-event reports; the expert evaluation of November 2021 ended that posture, and individual recommendations resumed in April 2022. The vaccine remained in the national immunization program and publicly funded throughout — a suspension of proactive recommendation, not a ban.
積極的な勧奨を一時差し控える
The ministry's own page records that in June 2013 it temporarily withheld proactive recommendation of the HPV vaccine over adverse-event reports; the expert evaluation of November 2021 ended that posture, and individual recommendations resumed in April 2022. The vaccine remained in the national immunization program and publicly funded throughout — a suspension of proactive recommendation, not a ban. Verbatim ministry phrase quoted in Japanese as required; the page confirms the vaccine was never banned or delisted.